Methyl 4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzoate

Catalog No. :
ACMSFE515
CAS No. :
400074-56-8
Molecular Formula :
C14H10F3NO3
Molecular Weight :
297.23

IUPAC Name:methyl 4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzoate

Methyl 4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$566.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzoate
IUPAC Namemethyl 4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzoate
MDL No.MFCD00268985
Molecular FormulaC14H10F3NO3
Molecular Weight297.23
SMILESO=C(OC)C1=CC=C(OC2=NC=C(C(F)(F)F)C=C2)C=C1
InChI KeyBMUYNIQCOBVULZ-UHFFFAOYSA-N
Synonymmethyl 4-{[5-(trifluoromethyl)-2-pyridinyl]oxy}benzenecarboxylate;methyl 4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoate;Benzoic acid, 4-[[5-(trifluoromethyl)-2-pyridinyl]oxy]-, methyl ester
CAS No.400074-56-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMSFE515 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNXL593 route compound structure diagram
    ACBNXL5935026-62-0 In Stock
  2. Plus
  3. ACFRZX973 route compound structure diagram
    ACFRZX97352334-81-3 In Stock
  4. Then
  5. ACMSFE515 route product structure diagram
    ACMSFE515400074-56-8
Inquiry

2. ACMSFE515 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNXL593 route compound structure diagram
    ACBNXL5935026-62-0 In Stock
  2. Plus
  3. ACCPHV394 route compound structure diagram
    ACCPHV39450488-42-1 In Stock
  4. Then
  5. ACMSFE515 route product structure diagram
    ACMSFE515400074-56-8
Inquiry

Comments (0)